Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 260-266

  Ahmed, Naila ^a   Thornalley, Paul J ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

Albumin; Drug binding; Glycation; Methylglyoxal; Peptide mapping

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE DERIVATIVE; ARGPYRIMIDINE; CELL PROTEIN; HUMAN SERUM ALBUMIN; HYDROIMIDAZOLONE; IMIDAZOLE DERIVATIVE; LYSINE DERIVATIVE; METHYLGLYOXAL; N DELTA (5 HYDRO 5 METHYL 4 IMIDAZOLON 2 YL)ORNITHINE; N EPSILON (1 CARBOXYETHYL)LYSINE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; ENZYME ACTIVE SITE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MASS SPECTROMETRY; PEPTIDE MAPPING; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

EID: 23744491239     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1333.031     Document Type: Conference Paper

References (21)

1. THORNALLEY, P.J. 1999. Clinical significance of glycation. Clin. Lab. 45: 263-273.
2. AHMED, N., O.K. ARGIROV, H.S. MINHAS, et al. 2002. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by aminoquinolyl-N-hydroxysuccimidyl-carbamate and application to Nε-carboxymethyl-lysine-and Ne-(1-carboxyethyl)lysine-modified albumin. Biochem. J. 364(Pt. 1): 1-14.
3. AHMED, N. & P.J. THORNALLEY. 2002. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with aminoquinolyl-N-hydroxysuccimidyl-carbamate and intrinsic fluorescence. Biochem. J. 364(Pt. 1): 15-24.
4. THORNALLEY, P.J., S. BATTAH, N. AHMED, et al. 2003. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375: 581-592.
5. TAKAHASHI, K. 1968. The reaction of phenylglyoxal with arginine residues in proteins. J. Biol. Chem. 6171-6179.
6. WESTWOOD, M.E., O.K. ARGIROV, E.A. ABORDO & P.J. THORNALLEY. 1997. Methylglyoxal-modified arginine residues-a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta 1356: 84-94.
7. PETERS, T. 1996. All About Albumin. Academic Press. New York.
8. RUSSO, L.M., G.L. BAKRIS & W.D. COMPER. 2002. Renal handling of albumin: a critical review of basic concepts and perspective. Am. J. Kidney Dis. 39: 899-919.
9. SUGIO, S., A. KASHIMA, S. MOCHIZUKI, et al. 1999. Crystal structure of human serum albumin at 2.5 angstrom resolution. Protein Eng. 12: 439-446.
10. CURRY, S., H. MANDELKOW, P. BRICK & N. FRANKS. 1998. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5: 827-835.
11. PETITPAS, I., T. GRUNE, A.A. BHATTACHARYA & S. CURRY. 2001. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314: 955-960.
12. BHATTACHARYA, A.A., T. GRUNE & S. CURRY. 2000. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303: 721-732.
13. CHOI, J.K., J. HO, S. CURRY, et al. 2002. Interactions of very long-chain saturated fatty acids with serum albumin. J. Lipid Res. 43: 1000-1010.
14. IBERG, N. & R. FLUCKIGER. 2002. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylation sites. J. Biol. Chem. 261: 13542-13545.
15. GOLDBERG, A.L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
16. PETITPAS, I., A.A. BHATTACHARYA, S. TWINE, et al. 2001. Crystal structure analysis of warfarin binding to human serum albumin-anatomy of drug site I. J. Biol. Chem. 276: 22804-22809.
17. WATANABE, H., S. TANASE, K. NAKAJOU, et al. 2000. Role of arg-410 and tyr in human serum albumin for ligand binding and esterase-like activity. Biochem. J. 349: 813-819.
18. ε- (Carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274: 31740-31749.
19. NG, R., O.K. ARGIROV, N. AHMED, et al. 2002. Human serum albumin minimally modified by methylglyoxal binds to human mononuclear leukocytes via the RAGE receptor and is displaced by N-carboxymethyl-lysine and hydroimidazolone AGE epitopes. Excerpta Medica International Congress Series 1245. S. Horiuchi, N. Taniguchi, F. Hayase, et al., Eds.: 77-81. Elsevier. Amsterdam.
20. THORNALLEY, P.J. 2004. Glycation, receptor-mediated cell activation and vascular complications of diabetes. Diabetes Vasc. Dis. Res. 1: 21-22.
21. GALLET, X., B. CHARLOTEAUX, A. THOMAS & R. BRASEUR. 2000. A fast method to predict protein interaction sites from sequences. J. Mol. Biol. 302: 917-926.